FDA Inspection 1091237 — SGS North America Inc.

SGS North America Inc. — FEI 1418028

The FDA completed an inspection of SGS North America Inc. on Apr 24, 2019 in Lincolnshire, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lincolnshire, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.